Scott Andrew Smith is President at BioAtla, Inc. (BCAB). They have made 8 open-market trades across 3 companies since 2019, most recently 2026-03-06.
CIK 0001614975
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $805K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTRS | BUY | 2025-08-12 | 2025-08-13 | $9.99 | $220K | +1.9% | -3.8% | +8.2% |
| VTRS | BUY | 2025-05-12 | 2025-05-14 | $8.94 | $536K | +1.4% | +5.2% | +19.3% |
| BCAB | SELL | 2021-11-30 | 2021-12-07 | $22.05 | $155K | -15.1% | -31.3% | -76.9% |
| BCAB | SELL | 2021-11-29 | 2021-12-06 | $23.89 | $10K | -15.5% | -24.2% | -76.6% |
| BCAB | SELL | 2021-11-22 | 2021-11-30 | $25.27 | $40K | -15.6% | -19.0% | -74.1% |
| BCAB | SELL | 2021-10-01 | 2021-10-07 | $30.18 | $181K | -2.4% | +6.9% | -37.0% |
| BCAB | SELL | 2021-08-26 | 2021-08-30 | $40.15 | $2.7M | -6.7% | -23.7% | -41.4% |
| SBPH | BUY | 2019-06-28 | 2019-06-28 | $4.09 | $49K | +15.7% | +20.2% | -16.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.